Sophrosyne Technologies
DLI Beneficiary
TipWhy This Matters
Founded 2022 by Manish Srivastava. Raised $2M seed funding from Bluehill Capital shortly after securing a ~$1.2M (₹10 crore) DLI grant from MeitY. R&D and product-design centre based in Udupi.
What does this firm design?
A multi-vital biosensing SoC consolidating ECG, PPG, respiration, and temperature monitoring into a single ultra-low-power chip for compact, energy-efficient medical wearables.
Key Facts
| Category | DLI Beneficiary |
| Parent Company | None (Indian-origin) |
| Founded | 2022 |
| India Headcount | Not publicly disclosed |
| Locations | Udupi |
| Product Focus | Multi-vital biosensing SoC for wearables |
| Application Domains | Healthcare, Wearables |
| Design Scope | Full chip |
| Node Sophistication | Not applicable / not disclosed |
| DLI Beneficiary | Yes |
Design Score
Not yet scored
Sources
- DLI Scheme beneficiary list (27 Jun 2026)
- Semiconductor Startup Sophrosyne Bags $2 Mn From Bluehill VC (Inc42) (01 Jan 2026)
NoteHave an update about this firm?
If you have new information, a correction, or a source to add, please submit it via our form or open a GitHub Issue.